Nanobac Pharmaceuticals Incorporated (NNBP)
OTHER OTC:NNBP
Holding NNBP?
Track your performance easily

Nanobac Pharmaceuticals (NNBP) Financial Statements

5 Followers

Nanobac Pharmaceuticals Financial Overview

Nanobac Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Nanobac Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 07Sep 07Jun 07Mar 07Dec 06
Income Statement-
Total Revenue$ 4.37K$ 5.81K$ 2.43K$ 5.01K$ 2.34K
Gross Profit$ 678.00$ 1.14K$ 530.00$ 752.00$ 1.64K
EBIT$ -1.14M$ -535.48K$ 679.92K$ -2.56M$ -1.83M
EBITDA$ -1.03M$ -420.93K$ 795.20K$ -2.44M$ -1.71M
Net Income Common Stockholders$ -1.17M$ -835.76K$ -716.56K$ -3.86M$ -1.86M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 3.93K$ 661.00$ 967.00$ 6.23K$ 39.51K
Total Assets$ 7.22M$ 7.34M$ 7.55M$ 7.63M$ 7.82M
Total Debt$ 4.12M$ 3.92M$ 3.63M$ 3.31M$ 5.37M
Net Debt$ 4.12M$ 3.92M$ 3.63M$ 3.30M$ 5.33M
Total Liabilities$ 9.58M$ 9.50M$ 8.62M$ 7.97M$ 9.14M
Stockholders Equity$ -2.36M$ -2.16M$ -1.07M$ -345.05K$ -1.31M
Cash Flow-
Free Cash Flow$ -110.32K$ -200.28K$ -285.07K$ -316.75K$ -658.51K
Operating Cash Flow$ -110.32K$ -200.28K$ -285.07K$ -315.21K$ -669.66K
Investing Cash Flow$ -301.00$ -3.22K$ 0.00$ 52.09K$ -8.16K
Financing Cash Flow$ 157.58K$ 241.05K$ 274.47K$ 237.79K$ 637.35K
Currency in USD

Nanobac Pharmaceuticals Earnings and Revenue History

Nanobac Pharmaceuticals Debt to Assets

Nanobac Pharmaceuticals Cash Flow

Nanobac Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis